Joan-Marc Servitja
Grupo de investigación
- Patogenia y prevención de la diabetes Accredited researcher (R3A)
Sobre mí
Dr. Joan-Marc Servitja is a senior researcher at the group Pathogenesis and Prevention of Diabetes, leading different projects related to islet biology and diabetes. He has also received contracts from the pharmaceutical industry in order to test novel applications of existing drugs as potential treatments for type 1 and type 2 diabetes. During the last years, he has authored more than 20 articles on diabetes research published in high impact journals.
Currently, he is leading different research lines focused on the regulation of gene expression and inter-organ cross-talk in pancreatic islets with the ultimate goal to design novel therapeutic strategies for the treatment of type 2 diabetes.
Publicaciones destacadas
-
High Intensity Interval Training reduces hypoglycemic events compared with continuous aerobic training in individuals with type 1 diabetes: HIIT and hypoglycemia in type 1 diabetes
Autores:Referencia: Diabetes & Metabolism 2022. -
BACE2 suppression in mice aggravates the adverse metabolic consequences of an obesogenic diet
Autores:Referencia: Molecular Metabolism 2021. -
4-Phenylbutyrate (PBA) treatment reduces hyperglycemia and islet amyloid in a mouse model of type 2 diabetes and obesity
Autores:Referencia: Scientific Reports 2021. -
Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction
Autores:Referencia: Molecular Metabolism 2020. -
Stress-Induced MicroRNA-708 Impairs β-Cell Function and Growth.
Autores:Referencia: Diabetes 2017. -
BACE2 suppression promotes β-cell survival and function in a model of type 2 diabetes induced by human islet amyloid polypeptide overexpression.
Autores:Referencia: Cellular And Molecular Life Sciences 2017. -
Mitochondrial Dynamics Mediated by Mitofusin 1 Is Required for POMC Neuron Glucose-Sensing and Insulin Release Control.
Autores:Referencia: Cell Metabolism 2017. -
Islet amyloid polypeptide exerts a novel autocrine action in b-cell signaling and proliferation
Autores:Referencia: Faseb Journal 2015. -
Circulating miR-192 and miR-193b are markers of prediabetes and are modulated by an exercise intervention
Autores:Referencia: Journal Of Clinical Endocrinology & Metabolism 2015.
Proyectos destacados
-
Inter-organ cross-talk and type 2 diabetes: effects of circulating exosomes on pancreatic islets
Investigador/a principal: Anna Maria Novials Sarda, Joan Marc Servitja DuqueFinanciador: Instituto de Salud Carlos IIICódigo: PI20/00658Duración: 01/01/2021 - 31/12/2023 -
Benchtop NMR for Lab-On-Chip (BLOC)
Investigador/a principal: Joan Marc Servitja DuqueFinanciador: European CommissionCódigo: 863037Duración: 01/01/2020 - 31/12/2023 -
BACE2, una nueva diana terapéutica para el tratamiento de la diabetes tipo 2 y la obesidad.
Investigador/a principal: Joan Marc Servitja Duque, Anna Maria Novials SardaFinanciador: Instituto de Salud Carlos IIICódigo: PI17/00879Duración: 01/01/2018 - 31/12/2020 -
Nuevas estrategias para el tratamiento de la diabetes: intervención sobre el estrés de retículo endoplásmico y la inflamación inducidos por los depósitos de amiloide en el islote pancreático.
Investigador/a principal: Joan Marc Servitja Duque, Anna Maria Novials SardaFinanciador: Instituto de Salud Carlos IIICódigo: PI14/00447Duración: 01/01/2015 - 31/12/2017 -
Potential protective effects of an anti-inflammatory molecule on pancreatic beta-cells.
Investigador/a principal: Joan Marc Servitja Duque, Anna Maria Novials SardaFinanciador: CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Sede o evento); Instituto Grifols, S.A. ; Instituto Grifols, S.A. (Participante)Duración: 01/01/2013